JPY 6,684.00
+3.69%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenJPY 6,700.00
From 52W high−36.07%
Volume2.85M
Market capJPY 11.00T
P/E (TTM)23.3x
P/S (TTM)8.2x
Div yield2.20%
Key dataSep 18, 2026
Open
JPY 6,700.00
From 52W high
−36.07%
Volume
2.85M
Market cap
JPY 11.00T
ValuationView details →
P/E (Fwd)
20.5x
EV/EBITDA
14.6x
P/E (TTM)
23.3x
RSI (14)
49.9
MomentumView details →
1D Return
+3.69%
YTD Return
−18.16%
Similar companies
Latest newsMore news →
Sandoz announced a licensing, development, manufacturing and commercialisation agreement with mAbxience for a proposed emicizumab biosimilar, with Sandoz holding exclusive global commercialisation rights excluding Argentina, Uruguay and Paraguay.2d agoOn September 15, US-listed ADRs of Japanese companies traded with a slight selling bias, with Chugai Pharmaceutical and Takeda Pharmaceutical among the decliners, while Chicago Nikkei 225 futures settled at 63,405 yen, 285 yen above the Osaka daytime level.5d ago